Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07498413 | Epidemiology and Treatment of HR+/HER2- Breast Cancer in England(ROTOR) | completed | — | 218,677 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 1, 2026 | clinicaltrials |
| NCT03947151 | Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer(DEGASTIM) | completed | Phase 2 | 8 | Assistance Publique - Hôpitaux de Paris |
| 1 |
| Mar 31, 2026 |
| clinicaltrials |
| NCT04013568 | Exercise Post-Diagnosis of Breast Cancer | completed | N/A | 62 | University of HawaiiOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT04354675 | Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer | completed | N/A | 35 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT04764682 | Determining Molecular Drivers of Radiation Dermatitis | completed | — | 20 | Mayo ClinicOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT05058196 | Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer(CARTE) | completed | N/A | 104 | UNICANCEROTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07126522 | Virtual Support Platform (HERCaRE Application) for the Improvement of Survivorship Among Black Breast Cancer Survivors | completed | N/A | 45 | Mayo ClinicOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT00003140 | Letrozole After Tamoxifen in Treating Women With Breast Cancer | completed | Phase 3 | 5,187 | NCIC Clinical Trials GroupNETWORK | 2 | Mar 27, 2026 | clinicaltrials |
| NCT00066443 | Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer | completed | Phase 1 / Phase 2 | 93 | NCIC Clinical Trials GroupNETWORK | 1 | Mar 27, 2026 | clinicaltrials |
| NCT03328026 | Combination Study of SV-BR-1-GM With Retifanlimab | completed | Phase 1 / Phase 2 | 36 | BriaCell Therapeutics CorporationINDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT03586297 | Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer | completed | — | 49 | Hackensack Meridian HealthOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT05376241 | Promoting Informed Choice for Breast Cancer Screening | completed | Phase 2 | 637 | University of Colorado, DenverOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06133647 | Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System | completed | — | 8 | Methodist Health SystemOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06305117 | Virtual RealiTy and mUsic in the Oncology SEtting - Phase 1(VRtuose1) | completed | N/A | 60 | International Agency for Research on CancerOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06435546 | Adherence to Oral Therapies in Advanced Breast and Prostate Cancers(AdOTAC) | completed | N/A | 200 | Institut de Cancérologie de LorraineOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07455110 | EORTC Quality of Life Measurement in Males With Breast Cancer(BR Male) | completed | — | 65 | Helios University Hospital WuppertalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT04998682 | Prospective Evaluation of Targeted Axillary Dissection (TAD)(TAD) | completed | N/A | 20 | University of MiamiOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT03440398 | Robotic Nipple-Sparing Mastectomy Vs Conventional Open Technique | completed | N/A | 82 | European Institute of OncologyOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT04539938 | A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer(HER2CLIMB-04) | completed | Phase 2 | 70 | Seagen, a wholly owned subsidiary of PfizerINDUSTRY | 1 | Mar 23, 2026 | clinicaltrials |
| NCT05963997 | A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer(SUMIT-ELA) | completed | Phase 1 / Phase 2 | 49 | Carrick Therapeutics LimitedINDUSTRY | 4 | Mar 23, 2026 | clinicaltrials |
| NCT07487129 | Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt(Clinical and P) | completed | Phase 4 | 206 | Beni-Suef UniversityOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT03714243 | Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases(BBBD) | completed | N/A | 8 | InSightecINDUSTRY | 1 | Mar 20, 2026 | clinicaltrials |
| NCT05397457 | Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia | completed | N/A | 106 | Chang Gung Memorial HospitalOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT07478939 | Study on the Level of Physical Activity in Patients Diagnosed With Breast Cancer in Spain(GYMNOS Project) | completed | — | 507 | Spanish Breast Cancer Research GroupOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT03651973 | Prevention of Sequelae Pain After Breast Cancer Surgery by Self-massages and Self Stretching. Impact of Learning Workshops.(ESTAUVAL) | completed | N/A | 143 | Center Eugene MarquisOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT03709446 | Leflunomide in Previously Treated Metastatic Triple Negative Cancers | completed | Phase 1 / Phase 2 | 17 | Joseph SparanoOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT05390229 | Screening Contrast-enhanced Mammography | completed | — | 231 | CHU de Quebec-Universite LavalOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT05659563 | Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%(EMPRESS) | completed | Phase 2 | 92 | MedSIROTHER | 2 | Mar 19, 2026 | clinicaltrials |
| NCT00959556 | Study of Blood Samples in Patients With Breast Cancer | completed | — | — | Centre Oscar LambretOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT02861742 | Impact of Emotional Skills of Young Women and Their Partner on Adjustment to Cancer(KALICOU3) | completed | N/A | 391 | Centre Oscar LambretOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT05286684 | Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis(Exo-LCR) | completed | N/A | 7 | Centre Oscar LambretOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06428799 | Evaluation of Carebot AI MMG Medical Device for Breast Lesion Detection and Density Assessment(EMBLEDDA-MMG) | completed | — | 122 | Carebot s.r.o.INDUSTRY | 1 | Mar 18, 2026 | clinicaltrials |
| NCT00893061 | Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer(MNEMOSYNE) | completed | Phase 3 | 44 | Centre Oscar LambretOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT02553967 | Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)(REMASCO) | completed | N/A | 49 | Centre Oscar LambretOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT02858063 | Psychometric Validation (Quality-of-life Scale) in Young Women With a Non Metastatic Breast Cancer and Her Partner(KALICOU2) | completed | — | 1,045 | Centre Oscar LambretOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT02900118 | Imaging Evaluation of the Therapeutic Response of Breast Cancer Bone Metastasis (EMOS)(EMOS) | completed | — | 28 | Centre Oscar LambretOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT03725436 | ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors | completed | Phase 1 | 28 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT04253561 | Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients(IPATHER) | completed | Phase 1 | 17 | SOLTI Breast Cancer Research GroupOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT05340413 | Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.(RADIOLA) | completed | Phase 2 | 65 | SOLTI Breast Cancer Research GroupOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07474246 | A Innovative Web-based Dance Movement Therapy | completed | N/A | 67 | Chin-Tsung ShenOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT01661816 | Breast Cancer and Quality of Life(KALICOU) | completed | — | 171 | Centre Oscar LambretOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT05373069 | BENEFIT OF MECHANICAL ISCHEMIC PRECONDITIONING ON TOLERANCE OF ADIPOSE TISSUE TO ISCHEMIA REPERFUSION OF TYPE DIEP (DEEP INFERIOR EPIGASTRIC PERFORATOR) FREE FLAPS.(PRIMIDIEP) | completed | N/A | 18 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT05677308 | LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS) | completed | — | 61 | AstraZenecaINDUSTRY | 1 | Mar 13, 2026 | clinicaltrials |
| NCT06078761 | Healthy Eating and Active Lifestyle (HEAL): Breast Cancer Program Outcomes(HEAL BC) | completed | — | 22 | AdventHealthOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT06332508 | Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL) | completed | Phase 1 | 14 | National University Hospital, SingaporeOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT07328321 | Development and Assessment of the 8-item Chronic Pain Acceptance Questionnaire to Measure Disease Acceptance in Women With Breast Cancer(CPAQ-8-BC) | completed | — | 101 | G. d'Annunzio UniversityOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT07471113 | Mobile App-Supported HPV and Breast Cancer Awareness Program | completed | N/A | 70 | Ataturk UniversityOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT01480869 | Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients(VITACAL) | completed | Phase 3 | 215 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT03249389 | Assessing the Changes in Markers of Calcium Vitamin Metabolism of for Breast Cancer Adjuvant (CALCIOBS)(CALCIOBS) | completed | N/A | 146 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT03252912 | Study in Leptomeningeal Metastases of Breast Cancer(LCS Bio Sein) | completed | N/A | 51 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Mar 12, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Apr 1, 2026source: clinicaltrials